Listing of Equity Shares of Kwality Pharmaceuticals Limited

• Notice No: 20160715-11
• Notice Date: 15 Jul 2016
• Category: Company related
• Segment: SME

 Trading Members of the Exchange are hereby informed that effective from Monday, July 18, 2016, the Equity Shares of Kwality Pharmaceuticals Limited shall be listed and admitted to dealings on the SME Platform of Exchange in the list of ‘MT’ Group of Securities.

Name of the company	Securities	Market Lot	Scrip Code
Kwality Pharmaceuticals Limited	51,88,099 equity shares of Rs. 10/- each fully paid up Distinctive Nos. 1 to 5188099.	3000 Shares	539997
Registered Office: Village Nagkalan, Majitha Road, Amritsar– 143 601, Punjab, India. Tel: [phone] Fax: [phone] Email: [e-mail] Website: www.kwalitypharma.com	Abbreviated name on bolt system KPL	Scrip ID on BOLT System KPL	ISIN No. INE552U01010
Issue Price: Rs. 45/- per share (Face Value of Rs.10/- with Rs. 35/- Premium)		Date of Allotment in the public issue: July 13, 2016

1.    Trading Members may note that as per the guidelines issued by SEBI dated 16^th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e. 3000 equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of atleast one month.

2.    The trading in the scrip shall continue to remain in Trade-for-Trade segment till further notice since 100%     of promoter shareholding of the company is not in dematerialized form, as per extent SEBI guidelines.

3.   Trading Members are requested to note that the above security will be available for trading in continuous trading session.

4.    Trading Members may note that the shares bearing the distinctive numbers, the details of which are attached as Annexure I, are not transferable till the date(s) mentioned against them and would not be a good delivery in the market till then. The company has informed the Exchange that in respect of shares in physical form, the respective share certificates have been enfaced with their non-transferability. The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository’s records.

5.     A copy of shareholding pattern submitted by the company is enclosed as Annexure II.

6.     The company’s financial year ending is March 31.

7.     All shares are ranking pari-passu including dividend entitlement.

8.     The Market Maker to the issue as mentioned in the prospectus is given below:

Guiness Securities Limited

Guiness House

18, Deshapriya Park Road,

Kolkata-700 026.

                           Tel: [phone]

Fax: [phone]

Email: [e-mail]

SEBI Registration No: INB 11146033

8.    The Registrar to the issue as mentioned in the prospectus is given below:

Big Share Services Private Limited

E/2, Ansa Industrial Estate,

Sakivihar Road,

Sakinaka, Andheri (E),

Mumbai - 400 072.

Tel No.: [phone]

Fax No.: [phone]

Email: [e-mail]

Website: www.bigshareonline.com

SEBI Regn No. INR000001385

Contact Person: Mr. Ashok Shetty

In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:

a) At the company: Ms. Pallavi Agarwal, Company Secretary and Compliance Officer	Registered Office: Village Nagkalan, Majitha Road, Amritsar– 143 601, Punjab, India. Tel: [phone] Fax: [phone] Email: [e-mail] Website: www.kwalitypharma.com
b) At the Exchange:      Rupal Khandelwal      Manager	Tel.: (91) 022 22728262

Rupal Khandelwal
Manager

Friday, July 15, 2016